![Charles Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Roberts
Gründer bei
Relation Therapeutics Ltd.
Profil
Charles Campbell Roberts was the founder of Yourgene Health Ltd. (2014), serving as Director from 2014 to 2016.
Mr. Roberts was the founder of Agalimmune Ltd. (2013), serving as Director from 2013 to 2016.
Mr. Roberts was the founder of Centauri Therapeutics Ltd. (2013), serving as Director from 2013 to 2016.
Mr. Roberts is the founder of Relation Therapeutics Ltd. (2020), serving as Chairman since 2020.
Mr. Roberts was the founder of Freenome Holdings, Inc. (2014), serving as Chief Growth Officer.
Current jobs include Advisory Council at ARK Venture and Chief Investment Strategist at ARK Investment Management LLC since 2023.
Former jobs include Advisor at Elevance Health, Inc. from 2020 to 2021 and Advisory at X PRIZE Foundation from 2011 to 2014.
Education includes graduate degree from the University of Oxford in 2014, undergraduate degree from University College London, and undergraduate degree from the University Of Dundee in 2002.
Aktive Positionen von Charles Roberts
| Unternehmen | Position | Beginn |
|---|---|---|
ARK Ventures
 ARK Ventures Investment ManagersFinance ARK Venture invests in companies located in the United states. The firm targets companies operating in the fields of AI & next generation internet, space & defense innovation, autonomous technology & robotics, digital assets & fintech innovation, and genomic revolution & biotech. It provides financing for early stage capital requirements. | Berater | - |
Relation Therapeutics Ltd.
 Relation Therapeutics Ltd. BiotechnologyHealth Technology Operates as an end-to-end biotech developing transformational medicines | Gründer | 01.01.2020 |
ARK Investment Management LLC
 ARK Investment Management LLC Investment ManagersFinance ARK focuses solely on offering investment solutions to capture disruptive innovation in the public equity markets. The firm employs an open research approach that adds technology concepts and external inputs to traditional financial research, creating a more transparent and interdisciplinary investment process. Their active management focuses on the long-term effect of disruptive technologies. ARK aims to identify innovation early, capitalize on the opportunities, and provide long-term value to investors by combining top-down and bottom-up research. | Marktstratege | 01.12.2023 |
Ehemalige bekannte Positionen von Charles Roberts
| Unternehmen | Position | Ende |
|---|---|---|
| ELEVANCE HEALTH, INC. | Berater | 30.04.2021 |
Agalimmune Ltd.
 Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Develops anti-cancer immunotherapy technology | Gründer | 30.10.2016 |
| YOURGENE HEALTH | Gründer | 01.07.2016 |
Centauri Therapeutics Ltd.
 Centauri Therapeutics Ltd. BiotechnologyHealth Technology Operates as an immunotherapy biotechnology company that engages in discovery and development of novel molecules targeting life threatening diseases | Gründer | 30.03.2016 |
X PRIZE Foundation
 X PRIZE Foundation Miscellaneous Commercial ServicesCommercial Services Creates educational programming for students and space enthusiasts | Berater | 30.09.2014 |
Ausbildung von Charles Roberts
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
ARK Investment Management LLC
ARK Investment Management LLC Investment ManagersFinance ARK focuses solely on offering investment solutions to capture disruptive innovation in the public equity markets. The firm employs an open research approach that adds technology concepts and external inputs to traditional financial research, creating a more transparent and interdisciplinary investment process. Their active management focuses on the long-term effect of disruptive technologies. ARK aims to identify innovation early, capitalize on the opportunities, and provide long-term value to investors by combining top-down and bottom-up research. | Finance |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elevance Health, Inc.
 Elevance Health, Inc. Managed Health CareHealth Services Provides health plans, clinical, behavioral, pharmacy and complex-care solutions | Health Services |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X PRIZE Foundation
X PRIZE Foundation Miscellaneous Commercial ServicesCommercial Services Creates educational programming for students and space enthusiasts | Commercial Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yourgene Health Plc
 Yourgene Health Plc Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
Agalimmune Ltd.
Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Develops anti-cancer immunotherapy technology | Health Technology |
Centauri Therapeutics Ltd.
Centauri Therapeutics Ltd. BiotechnologyHealth Technology Operates as an immunotherapy biotechnology company that engages in discovery and development of novel molecules targeting life threatening diseases | Health Technology |
Freenome Holdings, Inc.
 Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Health Technology |
ARK Ventures
ARK Ventures Investment ManagersFinance ARK Venture invests in companies located in the United states. The firm targets companies operating in the fields of AI & next generation internet, space & defense innovation, autonomous technology & robotics, digital assets & fintech innovation, and genomic revolution & biotech. It provides financing for early stage capital requirements. | Finance |
Relation Therapeutics Ltd.
Relation Therapeutics Ltd. BiotechnologyHealth Technology Operates as an end-to-end biotech developing transformational medicines | Health Technology |
